Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Segovia-Ayala
C. Segovia-Ayala
Boehringer Ingelheim
Medicine
Diabetes mellitus
Physical therapy
Essential hypertension
Supine position
3
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical efficacy and safety of telmisartan 80 mg once daily vs. atenolol 50 mg once daily in patients with mild-to-moderate hypertension.
2004
International Journal of Clinical Practice
L. Alcocer
P. Fernandez-Bonetti
Elena Campos
R. Olvera-Ruiz
J. Bahena
J.J. De La Fuente
C. Segovia-Ayala
R. Dominguez-Henkel
Show All
Source
Cite
Save
Citations (11)
Clinical efficacy and safety of telmisartan 80 mg once daily compared with enalapril 20 mg once daily in patients with mild-to-moderate hypertension: results of a multicentre study
2004
International Journal of Clinical Practice
L. Alcocer
P. Fernandez-Bonetti
Elena Campos
R. Dominguez-Henkel
J.J. De La Fuente
C. Segovia-Ayala
Show All
Source
Cite
Save
Citations (8)
Estudio doblemente a ciegas para evaluar la eficacia y seguridad de epinastina vs placebo en el tratamiento de la dermatitis por contacto
1998
S.C.J Novales
Alberto Ramos Garibay
A F Pérez
C. J. Ocampo
F. Amador
R. Gonzalez
R Domínguez Henkel
C. Segovia-Ayala
Show All
Source
Cite
Save
Citations (0)
1